Research graph
References from Suspected NIUAA after indobufen in a patient with ibuprofen allergy: a case report suggesting possible cross-reactivity. Local targets link to admitted publications; unresolved targets remain external evidence.
Indobufen: an updated review of its use in the management of atherothrombosis
10.2165/00002512-200118050-00007 · 2001 · External reference
Are drug provocation tests still necessary to test the safety of COX-2 inhibitors in patients with cross-reactive NSAID hypersensitivity?
10.1016/j.aller.2012.03.006 · 2013 · External reference
Safety of parecoxib in patients with nonsteroidal anti-inflammatory drug-induced urticaria or angioedema
10.1016/s1081-1206(10)60409-7 · 2008 · External reference
Characteristics of subjects experiencing hypersensitivity to non-steroidal anti-inflammatory drugs: patterns of response
10.1111/j.1365-2222.2010.03651.x · 2011 · External reference
Progress in understanding hypersensitivity reactions to nonsteroidal anti-inflammatory drugs
10.1111/all.14032 · 2020 · External reference
Self-reported drug allergy in a general adult Portuguese population
10.1111/j.1365-2222.2004.02070.x · 2004 · External reference
Preventability and severity assessment in reporting adverse drug reactions
1992 · External reference
Classification and practical approach to the diagnosis and management of hypersensitivity to nonsteroidal anti-inflammatory drugs
10.1111/all.12260 · 2013 · External reference
Cross-reactivity and tolerability of celecoxib in adult patients with NSAID hypersensitivity
10.1016/j.jaip.2019.04.042 · 2019 · External reference
Drug-induced hypersensitivity syndrome caused by cross-reaction of different COX-1 inhibitors: a case report [in Chinese]
10.13286/j.1001-5213.2025.22.18 · 2025 · External reference
An update on nonsteroidal anti-inflammatory drug-induced urticaria
10.2174/1871530323666230907112453 · 2024 · External reference
A multicenter retrospective study on hypersensitivity reactions to nonsteroidal anti-inflammatory drugs (NSAIDs) in children: a report from the european network on drug allergy (ENDA) group
10.1016/j.jaip.2019.10.049 · 2020 · External reference
Hypersensitivity to non-steroidal anti-inflammatory drugs (NSAIDs): classification of a Danish patient cohort according to EAACI/ENDA guidelines
10.1186/s13601-015-0052-0 · 2015 · External reference
Acute hemiballismus as the presenting feature of parietal lobe infarction
10.7759/cureus.4675 · 2019 · External reference
What we know about nonsteroidal anti-inflammatory drug hypersensitivity
10.3904/kjim.2016.085 · 2016 · External reference
Practical approach to hypersensitivity to nonsteroidal anti-inflammatory drugs (NSAIDs) in children
10.3390/ph16091237 · 2023 · External reference
Updating the classification and routine diagnosis of NSAID hypersensitivity reactions: a WAO statement
10.1016/j.waojou.2025.101086 · 2025 · External reference
Neurogenic pain and abnormal movements contralateral to an anterior parietal artery stroke
10.1001/archneur.60.7.1004 · 2003 · External reference
Tolerance of nonsteroidal anti-inflammatory drug-sensitive patients to the highly specific cyclooxygenase 2 inhibitors rofecoxib and valdecoxib
10.1016/s1081-1206(10)61282-3 · 2005 · External reference
A review on leukotrienes and their receptors with reference to asthma
10.3109/02770903.2013.823447 · 2013 · External reference
Tolerability to paracetamol and preferential COX-2 inhibitors in patients with cross-reactive nonsteroidal anti-inflammatory drugs hypersensitivity
10.5415/apallergy.2020.10.e29 · 2020 · External reference
Drug allergies documented in electronic health records of a large healthcare system
10.1111/all.12881 · 2016 · External reference
